Balatonfueredi Allami Szivkorhaz
- Address
- Gyogy Ter 2, 8230 Balatonfured, Hungary
Cardiovascular Diseases and Lipid Management Research
At Balatonfueredi Allami Szivkorhaz, much of the clinical trial activity focuses on cardiovascular diseases and related metabolic disorders, especially hyperlipidaemia, hypertension, and overall risk reduction in people with established or high-risk heart disease. These studies are designed to test new ways to lower harmful cholesterol and help prevent major heart and stroke events.
- Testing treatments to improve LDL cholesterol control in high-risk patients
- Evaluating therapies aimed at reducing heart attack and stroke risk
- Studying prevention strategies for people with established cardiovascular disease
This research area reflects a strong emphasis on better long-term protection for patients with elevated cardiovascular risk.
Hypertrophic Cardiomyopathy and Structural Heart Disease
The site is also active in studies of hypertrophic cardiomyopathy, including both obstructive and non-obstructive forms. These trials aim to improve symptoms, exercise ability, and heart structure in patients living with this complex inherited heart condition.
- Assessing treatments for symptom relief and better daily function
- Exploring ways to improve exercise capacity
- Using imaging to understand changes in heart muscle thickness and chamber size
The Cardiology Department at the site is contributing to research that may help refine care for patients with challenging structural heart disease.
Acute Coronary Syndromes and Emergency Heart Care
Another important focus is acute coronary syndrome, including recent-onset myocardial infarction cases. These trials look at faster, more effective treatment approaches for urgent heart events and aim to improve outcomes when every minute counts.
- Studying early treatment for suspected acute myocardial infarction
- Evaluating therapies started during or soon after hospital care
- Reducing the risk of repeat cardiac events after an acute episode
This area highlights the hospital’s role in research on rapid response and secondary prevention after serious heart emergencies.
Coronary Artery Disease, Angina, and Cardiometabolic Risk
Clinical trials at this site also include patients with refractory angina, coronary artery disease, and broader cardiometabolic risk. The goal is to evaluate new therapies that may reduce chest pain, improve blood flow-related symptoms, and lower the chance of future cardiovascular complications.
- Investigating treatments for persistent angina symptoms
- Assessing therapies for people with high cardiovascular risk
- Supporting research on prevention of coronary heart disease events
The research portfolio combines symptom-focused studies with prevention-oriented trials for patients at risk of serious heart disease.
Cardiomyopathy and Transthyretin Amyloidosis Research
The site is involved in research on less common but serious heart conditions such as transthyretin amyloidosis with cardiomyopathy. These studies are aimed at finding better treatments that may slow disease progression and improve survival and quality of life.
- Evaluating therapies for cardiomyopathy linked to amyloid disease
- Studying outcomes such as mortality and cardiovascular events
- Exploring options for patients with difficult-to-treat heart muscle disease
This work broadens the site’s research beyond common cardiovascular conditions into specialized heart failure-related disorders.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 5 by active trials.
- 1Alnylam Pharmaceuticals Inc.2active
lock +4 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Alnylam Pharmaceuticals Inc.2trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 332 other sites in Hungary
Therapeutic Area Benchmark — Hungary
Select a therapeutic area to compare against other sites in Hungary.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Hungary
Market Share
Country: Hungary
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Balatonfueredi Allami Szivkorhaz
lock Showing 1 of 9 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Subcutaneous Selatogrel in Preventing Recurrent Acute Myocardial Infarction in Post-AMI Patients | Viatris Innovation GmbH | Phase III | Recruiting | Jan 2022 | — |
IMP list
lock Showing 1 of 9 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Mavacamten | 2 | Unknown | 2023-04-13 | 2023-04-13 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.